JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor

JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor

Submitted by admin on January 11, 2023 - 11:08pm
Source: 
BioPharma Dive
News Tags: 
JPMHC 2023
Takeda
Bristol Myers Squibb
Prime Medicine
Sanofi
Headline: 
JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor
snippet: 

Executives at the two pharmas talked up their rival drugs at the J.P. Morgan Healthcare Conference, while Prime Medicine’s CEO pondered a busy future.

Do Not Allow Advertisers to Use My Personal information